Merck Animal Health, known as MSD Animal Health outside the United States and Canada, today announced the expansion of its portfolio of cattle implants with the introduction of REVALOR®-XH (trenbolone acetate and estradiol). REVALOR-XH features the same active ingredients as REVALOR-XS — the leading cattle industry implant — but is formulated specifically for use in feedyard heifers.
“REVALOR-XH begins to work immediately and provides the same strong finish that customers have come to expect from REVALOR-XS. It also provides the same level of convenience with the second dose going to work 70 to 80 days later, eliminating the need to re-process the cattle,” says Marshall Streeter, Ph.D., technical services specialist with Merck Animal Health. “With the addition of REVALOR-XH, feedyards now have a heifer implant strategy to improve performance, maintain feed intake and reduce stress, across a wide variety of feeding and marketing conditions.”
Performance-based implants, such as REVALOR-XH, provide marketing flexibility, while maintaining excellent feedyard performance and improving margin. Additionally, REVALOR-XH and REVALOR-XS help producers who may struggle with re-implanting challenges, such as weather events that delay re-implanting or result in increased maintenance costs and stressor exposure.
“Every time cattle are removed from their pen, moved across the feedyard, walked through the chute and returned to their original pen, the entire feeding operation experiences increased resource allocation demands and greater risk of injury to workers and cattle,” says Dr. Streeter. “When we disrupt cattle from their daily routine due to the re-implanting process, we may negatively affect performance and health, Revalor-XH helps to limit those disruptions.”
For more information on Revalor-XH, please contact your Merck Animal Health representative.